vs

Side-by-side financial comparison of COLONY BANKCORP INC (CBAN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $39.9M, roughly 2.1× COLONY BANKCORP INC). COLONY BANKCORP INC runs the higher net margin — 20.6% vs -38.1%, a 58.6% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 19.6%).

Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CBAN vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
2.1× larger
PRCT
$83.1M
$39.9M
CBAN
Higher net margin
CBAN
CBAN
58.6% more per $
CBAN
20.6%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
19.6%
CBAN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CBAN
CBAN
PRCT
PRCT
Revenue
$39.9M
$83.1M
Net Profit
$8.2M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
20.6%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
24.1%
-27.9%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAN
CBAN
PRCT
PRCT
Q1 26
$39.9M
$83.1M
Q4 25
$36.9M
$76.4M
Q3 25
$32.8M
$83.3M
Q2 25
$32.5M
$79.2M
Q1 25
$30.0M
$69.2M
Q4 24
$30.8M
$68.2M
Q3 24
$28.6M
$58.4M
Q2 24
$27.9M
$53.4M
Net Profit
CBAN
CBAN
PRCT
PRCT
Q1 26
$8.2M
$-31.6M
Q4 25
$-29.8M
Q3 25
$5.8M
$-21.4M
Q2 25
$8.0M
$-19.6M
Q1 25
$6.6M
$-24.7M
Q4 24
$-18.9M
Q3 24
$5.6M
$-21.0M
Q2 24
$5.5M
$-25.6M
Gross Margin
CBAN
CBAN
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
CBAN
CBAN
PRCT
PRCT
Q1 26
-4.1%
Q4 25
25.9%
-40.6%
Q3 25
22.2%
-27.8%
Q2 25
30.9%
-28.0%
Q1 25
27.6%
-39.7%
Q4 24
28.8%
-28.9%
Q3 24
24.6%
-38.4%
Q2 24
24.8%
-50.3%
Net Margin
CBAN
CBAN
PRCT
PRCT
Q1 26
20.6%
-38.1%
Q4 25
-39.1%
Q3 25
17.7%
-25.7%
Q2 25
24.6%
-24.7%
Q1 25
22.0%
-35.8%
Q4 24
-27.6%
Q3 24
19.7%
-35.9%
Q2 24
19.6%
-48.0%
EPS (diluted)
CBAN
CBAN
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.42
$-0.54
Q3 25
$0.33
$-0.38
Q2 25
$0.46
$-0.35
Q1 25
$0.38
$-0.45
Q4 24
$0.43
$-0.34
Q3 24
$0.32
$-0.40
Q2 24
$0.31
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAN
CBAN
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$295.8M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$380.4M
$347.7M
Total Assets
$3.7B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAN
CBAN
PRCT
PRCT
Q1 26
$295.8M
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
CBAN
CBAN
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$258.1M
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$248.0M
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CBAN
CBAN
PRCT
PRCT
Q1 26
$380.4M
$347.7M
Q4 25
$375.9M
$365.9M
Q3 25
$302.3M
$380.3M
Q2 25
$293.9M
$385.8M
Q1 25
$286.9M
$389.2M
Q4 24
$278.7M
$402.2M
Q3 24
$276.1M
$241.2M
Q2 24
$264.7M
$251.8M
Total Assets
CBAN
CBAN
PRCT
PRCT
Q1 26
$3.7B
$487.1M
Q4 25
$3.7B
$508.1M
Q3 25
$3.2B
$511.5M
Q2 25
$3.1B
$513.1M
Q1 25
$3.2B
$519.4M
Q4 24
$3.1B
$534.0M
Q3 24
$3.1B
$374.1M
Q2 24
$3.0B
$374.4M
Debt / Equity
CBAN
CBAN
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.69×
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.89×
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAN
CBAN

Net Interest Income$29.2M73%
Noninterest Income$10.7M27%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons